Skip to content

A Study on the Efficacy of CRET Therapy and Self-Heating Patches for Female University Students with Primary Dysmenorrhoea

A Study on the Efficacy of CRET Therapy and Self-Heating Patches for Female University Students with Primary Dysmenorrhoea

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123846
Enrollment
Unknown
Registered
2026-04-30
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhoea

Interventions

CRET Group:On the first day of the menstrual cycle, a single 20-minute session of transabdominal radiofrequency therapy was administered. The subject was positioned in the supine position with the low
the 10-minute CAP intervention and the 10-minute RES intervention provided 14.2 ± 1.2 kJ and 60.3 ± 5.3 kJ of energy, respectively. To ensure the standardisation and consistency of the CRET interventi

Sponsors

Beijing Sport University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 28 Years

Inclusion criteria

Inclusion criteria: 1.female university students aged 18–28; 2.meeting the diagnostic criteria for primary dysmenorrhoea (as screened by the Primary Dysmenorrhoea Questionnaire); 3.having experienced a Visual Analogue Scale (VAS) score of >=40 mm for menstrual pain on at least one occasion during the past three menstrual cycles; 4.having a regular menstrual cycle (21–35 days); 5.and willing to participate in this study and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Diagnosed as secondary dysmenorrhea; 2. Complicated with serious cardiovascular, liver, kidney, hematopoietic system and other diseases or mental diseases; 3. Skin damage, infection or paresthesia in the abdominal treatment area; 4. A pacemaker or other internal electronic device; 5. Allergy to hot patch adhesives or ibuprofen sustained-release capsules; 6. Recent (within 3 months) regular use of hormone drugs or participation in other clinical intervention trials; 7. Pregnant, preparing for pregnancy, or breastfeeding.

Design outcomes

Primary

MeasureTime frame
Pain intensity 4 hours after the intervention;

Secondary

MeasureTime frame
Overall burden of pain(Area under the pain intensity-time curve);Pain intensity at key time points;Speed of pain relief;Recurrence of pain;Rate of complete pain relief;Quantity of rescue medication used;Quality of life and mental well-being;Safety;Overall patient feedback;

Countries

China

Contacts

Public ContactSiqi Guo

Beijing Sport University

1402239660@qq.com+86 188 0108 6195

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026